← FDA DRUG APPROVALS

FDA ANDA · ANDA088147

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

Sponsor: HOSPIRA

APPLICATION
ANDA088147
TYPE
ANDA
ORIGINAL APPROVAL
1983-05-03
LATEST ACTION
1996-09-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%Discontinued
AMINOPHYLLINE 100MG/100ML · INJECTABLE · INJECTION
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%Discontinued
AMINOPHYLLINE 200MG/100ML · INJECTABLE · INJECTION

Approval history

1996-09-20Manufacturing (CMC) · Supplement 4AP
1989-04-28Labeling · Supplement 3AP
1984-11-15Manufacturing (CMC) · Supplement 1AP
1983-05-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →